The January Effect is a rise in asset prices often (but not always) observed throughout the month of January. There are a number of theories as to why this happens.
PSXP’s current short interest is on the high side compared to its average of ~1% since its inception in 2013.
As of January 11, 2017, DuPont traded at a one-year forward PE multiple of 20.00x compared to its peers Dow Chemical (DOW) and LyondellBasell (LYB).
Analysts’ consensus indicates a 12-month target price for DuPont at $78.10—a return potential of 5.5% from its closing price of $74.03 on January 11.
DuPont (DD) offers defined benefit plans to 80% of its employees across the world along with other long-term employee benefits.
DuPont’s (DD) stock price remained flat with a marginal gain of 0.6% from December 1, 2016, to January 11, 2017. DuPont has been trading sideways.
Of the 23 broker firms in Reuters’ survey, JNJ received “buy” ratings from ~39% of the firms, while ~61% of the firms rated the company a “hold.”
JNJ announced a quarterly cash dividend of $0.80 per share on January 3. This payment represents a dividend growth rate of 6.7% over the previous year.
JNJ posted better-than-expected 2Q16 earnings results on July 20, 2016. But its share price has fallen ~2% since October 18, 2016.
On January 3, DePuy Synthes, a subsidiary of Johnson & Johnson (JNJ), entered into an asset purchase and development agreement with Interventional Spine.
Johnson & Johnson (JNJ) has faced many litigations over the years, the most serious of which being its faulty hip replacement system lawsuits.
In 3Q16, Johnson & Johnson (JNJ) reported sales of $17.8 billion, representing a YoY (year-over-year) growth of ~4.2%.
On January 9, JNJ’s Medical Device division announced its Orthopedic Episode of Care Approach, a data-driven program that will accelerate value-based care.
On January 10, 2017, 18 brokerage companies were actively tracking 3M Company’s (MMM) stock. Among them, 44% of analysts recommended “buys” on the stock.
Currently, MMM is trading at a premium compared to HON and UTX. All three companies’ revenues have remained range-bound in the past three years.
3M (MMM) offers defined benefit plans to all its US employees and those outside the United States as a well. Overall, the company has 80 defined plans across 28 countries.
3M Company’s (MMM) stock rose 3.2% from the beginning of December 2016 to January 9, 2017. MMM’s stock is hovering near its 52-week high.
As of January 6, 2017, 22 brokerage firms were actively tracking Honeywell (HON) stock. 82% of these analysts recommended a “buy” for the stock.
As of January 6, 2017, HON was trading at a one-year forward PE multiple of 16.5x as compared to its peer United Technologies (UTX), which is trading at a one-year forward PE multiple of 17.2x.
Honeywell (HON) offers defined benefit plans that cover the majority of its employees and retirees in the United States and many other countries.